Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-173541
Filing Date
2025-08-05
Accepted
2025-08-05 16:13:30
Documents
15
Effectiveness Date
2025-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 d949175ds8.htm S-8 34012
2 EX-5.1 d949175dex51.htm EX-5.1 8039
3 EX-23.1 d949175dex231.htm EX-23.1 1290
4 EX-FILING FEES d949175dexfilingfees.htm   iXBRL EX-FILING FEES 24221
5 GRAPHIC g949175g0802072948235.jpg GRAPHIC 2533
  Complete submission text file 0001193125-25-173541.txt   197083

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d949175dexfilingfees_htm.xml XML 7558
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289250 | Film No.: 251185127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)